- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 351.13M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 348.41M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $37.9M |
| Capex | Q1 2026 · Mar 31, 2026 | $397.6M |
| Capex | Q1 2026 · Mar 31, 2025 | $243.3M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $107.6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $129.2M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $7.7B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $703.8M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $764M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $46.3M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $76.2M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.83B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.08B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $1.98B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $9.5B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $9.74B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.81B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.16B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $12.14B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $12.65B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.11B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.4B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $21.88B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $22.6B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.96 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$3.84 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$3.84 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $298.6M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $285.4M |
| Net Income | Q1 2026 · Mar 31, 2026 | $337.8M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.34B |
| Operating Income | Q1 2026 · Mar 31, 2026 | $23.8M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $60.7M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $426.6M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $403.4M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.27B |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.17B |